Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
---|---|---|---|
USD 15.69 Billion | USD 31.37 Billion | 8% | 2023 |
The global PCR Technologies market size was worth around USD 15.69 billion in 2023 and is predicted to grow to around USD 31.37 billion by 2032 with a compound annual growth rate (CAGR) of roughly 8.00% between 2024 and 2032.
The study provides historical data from 2018 to 2022 along with a forecast from 2024 to 2032 based on revenue (USD Billion). The report covers a forecast and an analysis of the PCR Technologies market on a global and regional level.
Polymerase chain reaction (PCR) is a technique of in-vitro enzymatic synthesis and amplification of small specific fragments of DNA to generate thousands to millions of copies of a DNA sequence. Currently, one of the most useful tools that is been extensively used in the field of molecular biology is PCR. It is been used for DNA fingerprinting, genetic testing, and tissue typing & mapping. To support PCR testing, several PCR technologies are available which include, qPCR machines, PCR workstations & cabinets, gradient PCR machines, and thermal cyclers.
The global PCR technologies market is growing at a significant rate. Some of the prominent factors that are propelling the growth of the global market are the growing prevalence of genetic disorders & target diseases, the increase in the shift towards the use of miniaturized portable instruments, and the growing use of biomarker profiling for the diagnosis of diseases. The PCR technologies are widely used for the diagnosis of a wide variety of autoimmune & genetic diseases, infections, and malignant neoplasms. PCR has enhanced the understanding of pathogenesis, improved the accuracy & rapidity of diagnosis, and also help identify the cause of infectious diseases due to its ability to detect minute amounts of RNA or DNA contained in fluids or tissues. In addition to this, rather than the whole genome, PCR focuses on an actual segment of DNA which enables the diagnosis of genetic disorders. In gene therapy cases, PCR is widely used to monitor the functioning of genes and gene segments.
All these factors coupled with the rise in the development of personalized medicine owing to the availability of personal genome testing and expanding field of nutrigenomics are fueling the growth of the global PCR technologies market. Moreover, factors such as growing research on rare diseases, rapid development in healthcare infrastructure in developing countries, and growing demand from forensic as well as research laboratories are spurring the growth of the global market. Furthermore, technological advancements to enhance the efficiency of existing technologies may behold numerous opportunities for the growth of the global PCR technologies market during the forecast period. However, the involvement of large capital investments for dPCR instruments may limit the growth of the global PCR technologies market.
The emergence of the Covid-19 pandemic has a positive impact on the global PCR technologies market. Genomic sequencing and identification by PCR is the key screening process in Covid-19 testing. The ability of precise and rapid diagnosis helped the healthcare providers to track as well as appropriately treat Covid-19 patients. With the increase in the Covid-19 patients across the world, the demand for PCR-based diagnostic tools and solutions also increased. This led to substantial growth in the global market amid the Covid-19 pandemic.
The global PCR technologies market is segregated based on product, technology, application, end-user, and region.
Based on the product, the global market is classified into services, software, instruments, and reagents & consumables.
Based on the technology, the global PCR technologies market is categorized into digital PCR, traditional PCR, real-time PCR, multiplex PCR, hot-start PCR, and others.
By application segment is bifurcated into forensic, research, clinical, and non-medical.
The end-user segment comprises hospitals & diagnostic labs, applied industries, pharma-biotech companies, academia & government organizations, and healthcare industry.
Report Attributes | Report Details |
---|---|
Report Name | PCR Technologies Market |
Market Size in 2023 | USD 15.69 Billion |
Market Forecast in 2032 | USD 31.37 Billion |
Growth Rate | CAGR of 8% |
Number of Pages | 193 |
Key Companies Covered | Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., Fluidigm Corporation, GE Healthcare, Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd., BioMérieux SA, Microsynth AG, Abbott Laboratories, and QIAGEN |
Segments Covered | By product, By technology, By application, By end-user and By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
Regionally, North America is projected to contribute to a maximum share in the global PCR technologies market. The presence of advanced technology, growing demand for personalized medicine, and rise in prevalence of genetic disorders are the major factors that are leading to the growth of the market in this region. Europe is anticipated to hold a significant share in the market. This is attributed to the growing investment in academic research and the rise in demand for rapid & accurate diagnosis of disease. On the other hand, the Asia Pacific market is expected to be the fastest growing due to the huge demand owing to the current Covid-19 pandemic situation and rise in prenatal genetic testing.
With the growing demand for PCR-based diagnostic tools and kits, the global PCR technologies market is witnessing strong competition to sustain in the market. Some of the key players operating in the market are:
By Product
By Technology
By Application
By End-User
Global PCR Technologies Market: Regional Segment Analysis
What Reports Provides
FrequentlyAsked Questions
Some of the prominent factors that are propelling the growth of the global market are the growing prevalence of genetic disorders & target diseases, the increase in the shift towards the use of miniaturized portable instruments, and the growing use of biomarker profiling for the diagnosis of diseases. Furthermore, technological advancements to enhance the efficiency of existing technologies may behold numerous opportunities for the growth of the global PCR technologies market during the forecast period.
With the growing demand for PCR-based diagnostic tools and kits, the global PCR technologies market is witnessing strong competition to sustain in the market. Some of the key players operating in the market are Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., Fluidigm Corporation, GE Healthcare, Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd., BioMérieux SA, Microsynth AG, Abbott Laboratories, and QIAGEN.
Regionally, North America is projected to contribute to a maximum share in the global PCR technologies market. The presence of advanced technology, growing demand for personalized medicine, and rise in prevalence of genetic disorders are the major factors that are leading to the growth of the market in this region.
According to study, the PCR Technologies Market size was worth around USD 15.69 billion in 2023 and is predicted to grow to around USD 31.37 billion by 2032.
The CAGR value of PCR Technologies Market is expected to be around 8.00% during 2024-2032.
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed